化学致癌剂4-NQO饮水法诱导小鼠口腔鳞癌模型的建立

doi:10.19438/j.cjoms.2019.04.003

中国口腔颌面外科杂志 ›› 2019, Vol. 17 ›› Issue (4): 300-303.doi: 10.19438/j.cjoms.2019.04.003

化学致癌剂4-NQO饮水法诱导小鼠口腔鳞癌模型的建立

傅友¹, 许可¹, 李江², 孙树洋¹, 张志愿¹

1.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科;
2.口腔病理科,国家口腔疾病临床医学研究中心,上海市口腔医学重点实验室,上海市口腔医学研究所,上海 200011

收稿日期:2019-01-10 修回日期:2019-03-28 出版日期:2019-07-20 发布日期:2019-08-12
通讯作者: 张志愿,E-mail：zhzhy@sjtu.edu.cn
作者简介:傅友（1992-）,男,在读硕士研究生,E-mail496932394@qq.com
基金资助:
国家重点研究开发项目(2017YFC0908500); 国家博士后科学基金（2017M610264）

Establishment of an oral squamous cell carcinoma model by using chemical carcinogen 4-NQO

FU You¹, XU Ke¹, LI Jiang², SUN Shu-yang¹, ZHANG Zhi-yuan¹

1. Department of Oromaxillofacial Head and Neck Oncology;
2.Department of Oral Pathology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology & Shanghai Research Institution of Stomatology. Shanghai 200011, China;

Received:2019-01-10 Revised:2019-03-28 Online:2019-07-20 Published:2019-08-12

摘要/Abstract

摘要： 目的：使用化学致癌剂4-硝基喹啉-1-氧化物（4-nitro-quinoline 1-oxide,4-NQO）诱导并建立C57BL/6小鼠口腔鳞癌病变模型。方法将4-NQO加入小鼠饮水,观察小鼠口腔黏膜的变化。于第12、16、20、24周处死,采集病变组织的样本,确定病变性质,并分离、培养肿瘤细胞。结果实验组小鼠在16周后口腔黏膜有明显的外生性肿物发生,直径约0.2 mm。小鼠口腔黏膜肿物H-E染色结果显示,肿物呈外生性或浸润性生长,可见角化珠和明显的核分裂象。细胞呈多边形,贴壁牢固,CK、Ki-67染色阳性,表明此细胞为鳞癌细胞。结论该模型诱导过程与人口腔鳞癌发病过程相似,是理想的研究口腔鳞癌发生、发展机制的动物模型。

关键词: 口腔鳞癌, 4-NQO, 动物模型, 细胞系

Abstract: PURPOSE: To establish a murine model with oral squamous cell carcinoma（OSCC）induced by chemical carcinogen 4-NQO. Methods: 4-NQO was added to drinking water for C57BL/6 mice, and the changes of oral mucosa were observed. The mice were sacrificed at various time points (12, 16, 20, 24 weeks), and the tissue samples were collected for identifying the characteristics and primary cell culture. Results: Mice in the experimental group had obvious exogenous tumors in the oral mucosa after 16 weeks, their diameters were about 0.2 mm. H-E staining of the tumors showed exogenous or invasive growth, with obvious keratinization and mitosis. The cells were polygonal and adherent to the wall firmly. CK and ki-67 staining was positive, indicating that the cells were squamous cell carcinoma cells. Conclusions: The induction process of this model is similar to that of human OSCC development, and it is an ideal animal model to study the mechanism of OSCC.

Key words: Oral squamous cell carcinoma, 4-NQO, Animal model, Cell line

中图分类号:

R739.8

傅友, 许可, 李江, 孙树洋, 张志愿. 化学致癌剂4-NQO饮水法诱导小鼠口腔鳞癌模型的建立[J]. 中国口腔颌面外科杂志, 2019, 17(4): 300-303.

FU You, XU Ke, LI Jiang, SUN Shu-yang, ZHANG Zhi-yuan. Establishment of an oral squamous cell carcinoma model by using chemical carcinogen 4-NQO[J]. China J Oral Maxillofac Surg, 2019, 17(4): 300-303.

参考文献

[1] De Moerlooze L, Spencer-Dene B, Revest JM, et al.An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis[J]. Development, 2000, 127(3): 483-492.
[2] Kang H, Kiess A, Chung CH.Emerging biomarkers in head and neck cancer in the era of genomics[J]. Nat Rev Clin Oncol, 2015, 12(1): 11-26.
[3] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424
[4] Gould SE, Junttila MR, de Sauvage FJ. Translational value of mouse models in oncology drug development[J]. Nat Med, 2015, 21(5): 431-439.
[5] de Visscher SA, Witjes MJ, van der Vegt B, et al. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model[J]. Lasers Surg Med, 2013, 45(10): 668-678.
[6] Miki K, Orita Y, Gion Y, et al.Tumor-associated macrophages in the development of 4-nitroquinoline-1-oxide-induced tongue squamous cell carcinoma in a mouse model[J]. Oncology, 2017, 93(3): 204-212.
[7] Young MR.Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer[J]. J Immunother, 2008, 31(2): 148-156.
[8] Tseng SH, Yang CC, Yu EH, et al.K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression[J]. Int J Cancer, 2015, 136(6): 1263-1275.
[9] Miki K, Orita Y, Gion Y, et al.Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma[J]. Cancer Immunol Immunother, 2016, 65(11): 1401-1410.
[10] Ohne M, Satoh T, Yamada S, et al.Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water[J]. Oral Surg Oral Med Oral Pathol, 1985, 59(6): 600-607.
[11] Hawkins BL, Heniford BW, Ackermann DM, et al.4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma[J]. Head Neck, 1994, 16(5): 424-432.
[12] Makita H, Tanaka T, Fujitsuka H, et al.Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin[J]. Cancer Res, 1996, 56(21): 4904-4909.
[13] Bi Y, Deng J, Murry DJ, et al.A whole-body physiologically based pharmacokinetic model of gefitinib in mice and scale-up to humans[J]. AAPS J, 2016, 18(1): 228-238.
[14] Olson B, Li Y, Lin Y, et al.Mouse models for cancer immunotherapy research[J]. Cancer Discov, 2018, 8(11): 1358-1365.
[15] Nagaya T, Nakamura Y, Okuyama S, et al.Syngeneic mouse models of oral cancer are effectively targeted by anti-CD44-based NIR-PIT[J]. Mol Cancer Res, 2017, 15(12): 1667-1677.
[16] Topalian SL, Taube JM, Anders RA, et al.Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy[J]. Nat Rev Cancer, 2016, 16(5):275-287.
[17] Rothschild U, Muller L, Lechner A, et al.Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions[J]. Swiss Med Wkly, 2018, 148: w14625.
[18] Yang Y.Cancer immunotherapy: harnessing the immune system to battle cancer[J]. J Clin Invest, 2015, 125(9): 3335-3337.

化学致癌剂4-NQO饮水法诱导小鼠口腔鳞癌模型的建立

Establishment of an oral squamous cell carcinoma model by using chemical carcinogen 4-NQO

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈华, 李婧, 罗梅. 红景天甙通过NRF2/KEAP1通路对口腔鳞癌细胞生长的影响[J]. 中国口腔颌面外科杂志, 2024, 22(5): 424-429.
[2]	黄灿, 罗涛, 孙宇. 改良衰弱评估对行口腔鳞癌皮瓣重建术老年患者术后并发症的预测价值[J]. 中国口腔颌面外科杂志, 2024, 22(4): 373-377.
[3]	米娜, 安玮, 金雪梅, 谢帅, 姚志涛. 叶黄素对兔创伤性颞下颌关节强直的预防作用研究[J]. 中国口腔颌面外科杂志, 2024, 22(3): 216-221.
[4]	李华盛, 周迪, 韩楠男, 严明, 阮敏. 石蒜碱通过降解SCAP蛋白抑制口腔鳞癌细胞增殖与侵袭的实验研究[J]. 中国口腔颌面外科杂志, 2024, 22(1): 29-35.
[5]	刘恒, 李永頔, 尹鑫海, 段晓峰. 铁蛋白重链1在头颈鳞癌中的表达及对口腔鳞癌增殖、迁移、侵袭的影响[J]. 中国口腔颌面外科杂志, 2023, 21(6): 529-537.
[6]	赵铜超, 梁思源, 周知航, 朱方兴, 琚梧桐, 谈亦然, 刘莹, 钟来平. BMI与局部晚期口腔鳞癌患者预后及诱导化疗效果的相关性研究[J]. 中国口腔颌面外科杂志, 2023, 21(6): 559-565.
[7]	朱方兴, 周知航, 琚梧桐, 谈亦然, 刘莹, 钟来平, 赵铜超. 基于基线期dNLR水平对局部晚期口腔鳞癌患者生存的预后预测—10年临床回顾[J]. 中国口腔颌面外科杂志, 2023, 21(6): 566-571.
[8]	靳能皓, 田瑜, 朱亮, 乔波, 李粮博, 张海钟, 张蕾. PD-L1及肿瘤免疫微环境对预测口腔鳞癌新辅助治疗效果的意义[J]. 中国口腔颌面外科杂志, 2023, 21(6): 572-578.
[9]	吴朱昊, 张兴伟, 孙亚威, 李子慧, 陈欣, 蒲玉梅, 胡勤刚, 董迎春, 孙国文. ICG荧光导航技术在晚期口腔鳞癌救治性手术中的应用[J]. 中国口腔颌面外科杂志, 2023, 21(3): 248-252.
[10]	刘恒, 段晓峰. 铁自噬及相关基因NCOA4、FTH1在口腔鳞癌中的研究进展[J]. 中国口腔颌面外科杂志, 2023, 21(1): 87-91.
[11]	季萍萍, 李莉, 吴奕帆, 侯黎莉. 经皮穴位电刺激防治口腔鳞癌患者诱导化疗后骨髓抑制的效果观察[J]. 中国口腔颌面外科杂志, 2022, 20(5): 455-460.
[12]	许刚, 宋其义, 蒋卫东, 刘景秀. 水通道蛋白3在口腔鳞癌中的表达及临床意义[J]. 中国口腔颌面外科杂志, 2022, 20(5): 478-482.
[13]	赵小妹, 夏荣辉, 钟来平, 朱东旺, 张志愿. Nrf2对口腔鳞癌患者TPF诱导化疗效果的影响[J]. 中国口腔颌面外科杂志, 2022, 20(4): 366-370.
[14]	张益益, 杨玥怡, 琚梧桐, 钟来平. 局部晚期口腔鳞癌新辅助免疫靶向治疗2例及文献复习[J]. 中国口腔颌面外科杂志, 2022, 20(4): 413-416.
[15]	魏东亮, 李智, 鞠侯雨, 吴云腾, 郭伟, 任国欣. EGFR靶向药物对口腔癌疼痛缓解作用的机制探讨[J]. 中国口腔颌面外科杂志, 2022, 20(3): 219-224.